Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib and Rituximab Maintenance in Mantle Cell Lymphoma
NCT02632396Phase 2Unknown
- Sponsor
- Emory University
- Start
- Mar 2016
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in mantle cell lymphoma (MCL), sponsored by Emory University. Status: unknown.
02
Drugs
ixazomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02632396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02632396.